{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T11:10:09Z","timestamp":1767006609872},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,15]]},"DOI":"10.7759\/cureus.25969","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T16:16:01Z","timestamp":1655309761000},"source":"Crossref","is-referenced-by-count":5,"title":["Small Fiber Neuropathy Associated With the Moderna SARS-CoV-2 Vaccine"],"prefix":"10.7759","author":[{"given":"Farzam","family":"Khokhar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anum","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaid","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianghong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9020160","article-title":"COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates","volume":"9","author":"Sallam M","year":"2021","unstructured":"Sallam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines (Basel). 2021, 9:160. 10.3390\/vaccines9020160","journal-title":"Vaccines (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.04.036","article-title":"Vaccine hesitancy: definition, scope and determinants","volume":"33","author":"MacDonald NE","year":"2015","unstructured":"MacDonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015, 33:4161-4. 10.1016\/j.vaccine.2015.04.036","journal-title":"Vaccine"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/ane.13417","article-title":"The potential neurological effect of the COVID-19 vaccines: a review","volume":"144","author":"Lu L","year":"2021","unstructured":"Lu L, Xiong W, Mu J, et al.. The potential neurological effect of the COVID-19 vaccines: a review. Acta Neurol Scand. 2021, 144:3-12. 10.1111\/ane.13417","journal-title":"Acta Neurol Scand"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/mus.10181","article-title":"Small-fiber neuropathy","volume":"26","author":"Lacomis D","year":"2002","unstructured":"Lacomis D. Small-fiber neuropathy. Muscle Nerve. 2002, 26:173-88. 10.1002\/mus.10181","journal-title":"Muscle Nerve"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-00996-y","article-title":"COVID-19 vaccine development: milestones, lessons and prospects","volume":"7","author":"Li M","year":"2022","unstructured":"Li M, Wang H, Tian L, et al.. COVID-19 vaccine development: milestones, lessons and prospects. Signal Transduct Target Ther. 2022, 7:146. 10.1038\/s41392-022-00996-y","journal-title":"Signal Transduct Target Ther"},{"key":"ref6","unstructured":"Our World in Data. Coronavirus (COVID-19) vaccinations. (2022). Accessed: May 31, 2022: https:\/\/ourworldindata.org\/covid-vaccinations."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/ane.13550","article-title":"Neurological side effects of SARS-CoV-2 vaccinations","volume":"145","author":"Finsterer J","year":"2022","unstructured":"Finsterer J. Neurological side effects of SARS-CoV-2 vaccinations. Acta Neurol Scand. 2022, 145:5-9. 10.1111\/ane.13550","journal-title":"Acta Neurol Scand"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2021\/e3286","article-title":"Post SARS-CoV-2 vaccination Guillain-Barre syndrome in 19 patients","volume":"76","author":"Finsterer J","year":"2021","unstructured":"Finsterer J, Scorza FA, Scorza CA. Post SARS-CoV-2 vaccination Guillain-Barre syndrome in 19 patients. Clinics (Sao Paulo). 2021, 76:e3286. 10.6061\/clinics\/2021\/e3286","journal-title":"Clinics (Sao Paulo)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9050435","article-title":"Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination","volume":"9","author":"Watad A","year":"2021","unstructured":"Watad A, De Marco G, Mahajna H, et al.. Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination. Vaccines (Basel). 2021, 9:435. 10.3390\/vaccines9050435","journal-title":"Vaccines (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27251","article-title":"Post COVID-19 vaccine small fiber neuropathy","volume":"64","author":"Waheed W","year":"2021","unstructured":"Waheed W, Carey ME, Tandan SR, Tandan R. Post COVID-19 vaccine small fiber neuropathy. Muscle Nerve. 2021, 64:E1-2. 10.1002\/mus.27251","journal-title":"Muscle Nerve"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2013-000758","article-title":"The clinical approach to small fibre neuropathy and painful channelopathy","volume":"14","author":"Themistocleous AC","year":"2014","unstructured":"Themistocleous AC, Ramirez JD, Serra J, Bennett DL. The clinical approach to small fibre neuropathy and painful channelopathy. Pract Neurol. 2014, 14:368-79. 10.1136\/practneurol-2013-000758","journal-title":"Pract Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/all.15302","article-title":"Autoantibodies in COVID-19 correlate with antiviral humoral responses and distinct immune signatures [Online version of record before inclusion in an issue]","author":"Taeschler P","year":"2022","unstructured":"Taeschler P, Cervia C, Zurbuchen Y, et al.. Autoantibodies in COVID-19 correlate with antiviral humoral responses and distinct immune signatures [Online version of record before inclusion in an issue]. Allergy. 2022, 10.1111\/all.15302","journal-title":"Allergy"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa433","article-title":"Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barr\u00e9 syndrome","volume":"144","author":"Keddie S","year":"2021","unstructured":"Keddie S, Pakpoor J, Mousele C, et al.. Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barr\u00e9 syndrome. Brain. 2021, 144:682-93. 10.1093\/brain\/awaa433","journal-title":"Brain"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202102_24877","article-title":"COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer\/BioNTech and Moderna vaccines","volume":"25","author":"Meo SA","year":"2021","unstructured":"Meo SA, Bukhari IA, Akram J, Meo AS, Klonoff DC. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer\/BioNTech and Moderna vaccines. Eur Rev Med Pharmacol Sci. 2021, 25:1663-9. 10.26355\/eurrev_202102_24877","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/100702-small-fiber-neuropathy-associated-with-the-moderna-sars-cov-2-vaccine","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:46:37Z","timestamp":1707507997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/100702-small-fiber-neuropathy-associated-with-the-moderna-sars-cov-2-vaccine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,15]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.25969","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,15]]}}}